PME
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

Pro Medicus Limited is an imaging IT provider delivering radiology information systems (RIS), Picture Archiving and Communication Systems (PACS), and advanced visualization solutions to hospitals, imaging centres, and healthcare groups worldwide. The company offers products for medical accounting, clinical reporting, appointments, scheduling, and marketing, alongside services including workflow mapping, network design, hardware configuration, and staff training. Its wholly-owned subsidiary, Visage Imaging, provides enterprise imaging solutions, including the Visage 7 Enterprise Imaging Platform, Visage RIS, Visage RIS/PACS, Visage Ease, and the Visage 7 Referrer Gateway. These solutions support diagnostic, clinical, specialty, research, and mobile imaging workflows, featuring vendor-neutral archives and artificial intelligence integrations. Pro Medicus serves clients ranging from small facilities to large hospital enterprises, emphasizing multi-site scalability and real-time business metrics reporting.

Summarised from the company's own disclosures, fiscal year ended Oct 2026

Industry Health Care Equipment & Services Homepage promed.com.au
Sector Technology IR page promed.com.au/investors
Tags
radiology information systems, picture archiving and communication systems, medical imaging, healthcare informatics, clinical reporting, workflow optimization, enterprise imaging, mobile diagnostics, Visage Imaging, Visage 7, Visage RIS, Visage RIS/PACS, Visage Ease, Visage Ease Pro, Visage 7 Referrer Gateway, Visage 7 Workflow, Visage 7 Open Archive, Visage AI Accelerator
Press page promed.com.au/news

Metrics

Valuation  
Market cap A$ 21.185B
Market cap (USD) $ 14.375B
P/E 79.84
PEG 1.26
P/BV 48.19
P/S 80.96
P/OCF 166.18
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 75.0%
ROI 58.8%
ROIC 58.8%
Profit margin 101.4%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 63.6%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 52.9%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012
Revenue 261.688M 212.98M 161.501M 124.9M 93.461M 67.884M 56.821M — — — 1.76M 48.089M 44.153M 11.154M —
Net profit 265.344M 115.217M 82.794M 60.648M 44.442M 30.85M 23.076M — — — — 3.217M 1.509M 5.131M —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012
Share price 122 — — — — — — — — — — — — — —
P/OCF 99.98 — — — — — — — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Change of Director's Interest Notice - Peter Kempen Bull 0 Bear 0 Routine
Becoming a substantial holder Bull 0 Bear 0 Routine

Prompts

Pro Medicus Limited (ticker PME), listed in Australia.

ETFs Holding Pro Medicus Limited

ETF Weight in ETF Shares Market value As of
DIHP 0.06% 28,936 $ 3.996M Nov 12, 2026
DFSI 0.04% 3,811 $ 526.299K Nov 12, 2026
AVSD 0.04% 1,070 $ 143.665K Nov 16, 2026
AVDE 0.03% 47,016 $ 6.313M Nov 16, 2026
JSTC 0.03% 659 $ 89.697K Nov 17, 2026
DXIV 0.02% 408 $ 56.345K Nov 12, 2026
DFAX 0.02% 18,947 $ 2.617M Nov 12, 2026
DFIC 0.02% 22,927 $ 3.166M Nov 12, 2026
DFAI 0.02% 25,401 $ 3.508M Nov 12, 2026